Cell Line : BCP-1
Cellosaurus Index : CVCL_0107
Cellosaurus ID : BCP-1
CCLE Name
: BCP1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
CTRP2 Name
: BCP1
Cancer Type : haematopoietic_and_lymphoid_tissue
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| BCP-1 | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | AA-COCF3 | CTRP2 | 0.0010 | 2.1000 |
|
| BCP-1 | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| BCP-1 | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| BCP-1 | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| BCP-1 | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | BRD-K63431240 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | BRD4132 | CTRP2 | 0.0049 | 80.0000 |
|
| BCP-1 | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| BCP-1 | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| BCP-1 | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | GSK461364 | CTRP2 | 0.0020 | 33.0000 |
|
| BCP-1 | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| BCP-1 | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | MI-1 | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | MIRA-1 | CTRP2 | 0.0020 | 17.0000 |
|
| BCP-1 | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| BCP-1 | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| BCP-1 | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Parthenolide | CTRP2 | 0.0020 | 33.0000 |
|
| BCP-1 | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | PI-103 | CTRP2 | 0.0011 | 37.0000 |
|
| BCP-1 | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| BCP-1 | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| BCP-1 | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| BCP-1 | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| BCP-1 | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| BCP-1 | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| BCP-1 | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| BCP-1 | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| BCP-1 | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| BCP-1 | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 17.0000 |
|
| BCP-1 | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| BCP-1 | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
IC50
Drugs with highest and lowest IC50
IC90
Drugs with highest and lowest IC90
AUC
Drugs with highest and lowest AUC